NASDAQ: MGRXMangoceuticals Inc Stock Ownership - Who owns Mangoceuticals?
Insider buying vs selling
Have Mangoceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Eugene M. Johnston | CFO | 2025-12-15 | 3,333 | $1.17 | $3.88kSell |
| Eugene M. Johnston | CFO | 2025-12-09 | 5,000 | $1.20 | $5.98kSell |
| Eugene M. Johnston | CFO | 2025-12-05 | 10,000 | $1.13 | $11.28kSell |
| Alex P. Hamilton | Director | 2025-11-19 | 125,000 | $1.22 | $152.88kSell |
MGRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MGRX insiders and whales buy or sell their stock.
MGRX Shareholders
What type of owners hold Mangoceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 9.05% | 1,536,000 | $645.12k | Institution |
| Jonathan Arango | 5.89% | 1,000,000 | $420.00k | Insider |
| Jacob D. Cohen | 3.57% | 605,000 | $254.10k | Insider |
| Vanguard Group Inc | 2.89% | 489,532 | $205.60k | Institution |
| Amanda Elizabeth Hammer | 1.03% | 175,000 | $73.50k | Insider |
| Ikarian Capital LLC | 0.81% | 138,146 | $58.02k | Institution |
| Kenny Myers | 0.81% | 136,667 | $57.40k | Insider |
| Lorraine Pamela Dalessio | 0.81% | 136,667 | $57.40k | Insider |
| Eugene M. Johnston | 0.71% | 120,000 | $50.40k | Insider |
| Geode Capital Management LLC | 0.64% | 108,322 | $45.50k | Institution |
MGRX vs Health Information Service Stocks
Mangoceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.